Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Breast cancer drug maker gets award for Arimidex
October 27th, 2005
Frost & Sullivan has awarded AstraZeneca the 2005 Pharmaceutical Industry Product of the Year Award for its hormonal breast cancer therapy, anastrozole (Arimidex). The award recognizes the advances in breast cancer treatment made by AstraZeneca through the development of anastrozole, a product now shown to be better at preventing the spread and return of cancer than tamoxifen, previously considered to be the "gold standard" therapy. The Frost & Sullivan Awards are recognized worldwide and are coveted across a broad array of industries, including healthcare, pharmaceuticals and telecommunications industries. The Product of the Year Award is presented...
Source: Women's Health Weekly (2005-10-27)
|
